Main takeaway
VisiFlora is not shown to be equivalent to the AREDS2 formulation studied by the National Eye Institute. AREDS2 is a defined set of nutrients at specified doses, with evidence for certain people with age-related macular degeneration (AMD)—not a universal cure for all vision changes. VisiFlora is presented as a broader supplement with other botanicals, and its seller-facing page does not confirm all ingredient amounts. NEI guidance · VisiFlora seller.
Side-by-side evidence table
| Feature | NEI-described AREDS2 formula | VisiFlora seller-facing information |
|---|---|---|
| Studied purpose | To reduce progression risk for eligible AMD patients | Marketed for general eye-nutrition support |
| Vitamin C | 500 mg | Named; exact amount not authenticated here |
| Vitamin E | 400 IU | Named; exact amount not authenticated here |
| Zinc | 80 mg | 11 mg stated on seller page |
| Copper | 2 mg | Named; exact amount not authenticated here |
| Lutein | 10 mg | Named; amount not confirmed in seller-facing text |
| Zeaxanthin | 2 mg | Named; amount not confirmed in seller-facing text |
| Beta-carotene | Not in AREDS2 formulation | Seller names vitamin A as beta-carotene |
| Other botanicals | Not part of NEI's specified formula | Seller lists ginkgo, bilberry, saffron and others |
| Direct outcome evidence | AREDS/AREDS2 trials in defined AMD populations | Finished-product VisiFlora trial not independently verified |
Comparison overview
Evidence contextRelated visual gallery
These additional visuals are included on this page to make the review easier to follow and more engaging for readers.
All visuals on this website are original editorial illustrations or reference imagery added to improve readability. They are not medical proof, testimonials or guarantees of results.
Reference values: NEI AREDS2 supplement page. VisiFlora column: seller overview.
Who may benefit from AREDS2?
According to the NEI, AREDS2 formulations may be appropriate for people with intermediate AMD in one or both eyes, or late AMD in one eye to help slow progression in the other eye. They are not established for preventing early AMD in people without those conditions, and they do not reverse existing damage. An eye-care professional can determine the stage and suitability for an individual. NEI.
Why does beta-carotene matter?
AREDS2 substituted lutein and zeaxanthin for beta-carotene, in part because of lung-cancer safety concerns identified in current/former smokers receiving high-dose beta-carotene-containing formulations. VisiFlora's promotional ingredient listing includes beta-carotene. This does not establish the same risk for the VisiFlora dose, which needs authentication, but it is an important question for current and former smokers and their clinicians. NEI AREDS2 FAQs · NIH ODS.
What about VisiFlora's additional botanicals?
More ingredient names do not necessarily mean better outcomes. A broader formula creates more variables to examine: quantity, interaction potential, ingredient standardization, manufacturing consistency and direct clinical performance. The correct question is whether the exact marketed product has demonstrated benefit on relevant endpoints. Our evidence review finds no independently authenticated finished-product trial.
Can someone take both together?
Do not combine eye supplements casually. Overlapping nutrients and potential medication interactions mean the total daily intake matters. Ask the clinician managing AMD or other eye conditions to assess the full labels and your personal risks, especially before adding a beta-carotene-containing supplement.
Comparison verdict
For patients who qualify for AREDS2, the studied, specified AREDS2 formula and their eye-care team's advice should be the basis of decisions. VisiFlora has a different marketed positioning and should not be marketed as a proven replacement. For people without AMD, neither product is a substitute for routine eye examinations, a healthy diet or attention to symptoms. Further options.